- Home
- GRPN vs ELVN Comparison
GRPN vs ELVN Comparison
Compare GRPN & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRPN
- ELVN
- Stock Information
- Founded
- GRPN 2008
- ELVN 2016
- Country
- GRPN United States
- ELVN United States
- Employees
- GRPN N/A
- ELVN N/A
- Industry
- GRPN Advertising
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- GRPN Consumer Discretionary
- ELVN Health Care
- Exchange
- GRPN Nasdaq
- ELVN Nasdaq
- Market Cap
- GRPN 791.8M
- ELVN 927.8M
- IPO Year
- GRPN 2011
- ELVN 2020
- Fundamental
- Price
- GRPN $29.13
- ELVN $17.77
- Analyst Decision
- GRPN Buy
- ELVN Strong Buy
- Analyst Count
- GRPN 4
- ELVN 4
- Target Price
- GRPN $18.75
- ELVN $37.25
- AVG Volume (30 Days)
- GRPN 1.8M
- ELVN 361.5K
- Earning Date
- GRPN 05-07-2025
- ELVN 05-14-2025
- Dividend Yield
- GRPN N/A
- ELVN N/A
- EPS Growth
- GRPN N/A
- ELVN N/A
- EPS
- GRPN N/A
- ELVN N/A
- Revenue
- GRPN $486,660,000.00
- ELVN N/A
- Revenue This Year
- GRPN $3.50
- ELVN N/A
- Revenue Next Year
- GRPN $7.31
- ELVN N/A
- P/E Ratio
- GRPN N/A
- ELVN N/A
- Revenue Growth
- GRPN N/A
- ELVN N/A
- 52 Week Low
- GRPN $7.75
- ELVN $13.30
- 52 Week High
- GRPN $29.93
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- GRPN 77.45
- ELVN 49.54
- Support Level
- GRPN $25.65
- ELVN $15.81
- Resistance Level
- GRPN $29.93
- ELVN $17.54
- Average True Range (ATR)
- GRPN 1.23
- ELVN 1.30
- MACD
- GRPN 0.23
- ELVN -0.04
- Stochastic Oscillator
- GRPN 84.25
- ELVN 38.06
About GRPN Groupon Inc.
Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.